Shasun Pharmaceuticals has dipped 5% to Rs 61 after the drug firm said that the operations at its Pondicherry facility have been affected due to strike by workers.
“An illegal strike was resorted by the workers at the company's Pondicherry facility (API and Formulation) on June 15, 2013,” Shasun Pharma said in a BSE filing.
The company is doing needful to resume the operations at the earliest, it added.
The stock opened at Rs 65.85 and hit low of Rs 55.50, its lowest value since January 2012, on BSE. A combined 1.58 million shares have changed hands on the counter till 1355 hours against an average less than 150,000 shares that were traded daily in past two weeks on BSE and NSE.
“An illegal strike was resorted by the workers at the company's Pondicherry facility (API and Formulation) on June 15, 2013,” Shasun Pharma said in a BSE filing.
The company is doing needful to resume the operations at the earliest, it added.
The stock opened at Rs 65.85 and hit low of Rs 55.50, its lowest value since January 2012, on BSE. A combined 1.58 million shares have changed hands on the counter till 1355 hours against an average less than 150,000 shares that were traded daily in past two weeks on BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%